The accelerating pace of change driven by cloud, mobile and big data requires application delivery pipelines to be faster and more agile than ever. IT teams that rely on traditional methods alone find that they’re unable to keep pace with demand, resulting in growing backlogs and missed opportunities.
Join this webinar to see how HP Helion Development Platform is enhanced with visual, model-driven app development by Mendix for HP Helion. Learn best practices for cloud-native rapid app development and how Mendix enables agile app development for 6-10 times faster results than traditional methods. We’ll take you through the complete application lifecycle—from visual design and development to one-click deployment and auto-scaling—and show you how to get started with these powerful capabilities.
Tired of coding constraints and complexity, vendor lock-in, and under-performing apps? The HP Helion Development Platform can help. Start rapidly developing, deploying, and delivering cloud-native applications. Learn how HP is using open source such as Cloud Foundry, OpenStack and Docker to change and accelerate developing cloud-native applications. Get an inside look at the architecture of the HP Helion Development Platform, details on how it works and why. Learn how to push code to the platform in one simple click, scale an application and how the platform supports the needs of developers with a polyglot runtime, frameworks and highly available services.Read more >
Method development and validation are essential parts of the pharmaceutical drug approval process. As process modifications are made and approval criteria become increasingly stringent, changes to the validated method are sometimes necessary. A Quality by Design (QbD) approach to method development uses statistical design of experiments (DoE) to generate a robust method ‘design space’. The design space defines a region in which changes to method parameters will not significantly affect the results, incorporating risk-based assessment of the final method. Rather than developing and validating a single method and proceeding through re-validation as modifications are made, a design space incorporates allowable flexibility into the method.
A QbD approach is demonstrated here in the development of a stability-indicating method, using UPLC for fast, sensitive separations, and software-driven validation. The flexibility of transferring methods between UPLC and HPLC will also be demonstrated. This streamlined approach to method development affords considerable cost savings as well as a significantly more robust and quality submission to regulatory authorities for faster drug approval.
+Do your clinical and administrative leaders have an adversarial relationship, rather than a partnership?
+Are your service line leadership teams struggling to be effective as clinical leaders and business leaders?
+Are your nurse leaders spending too much time managing unit drama and not enough time leading their teams?
Join us on October to learn how we've helped other healthcare organizations increase effectiveness and how you can too!
Pressures in health care for cost-containment, evidence based medicine/quality approaches, and a changing healthcare landscape make it essential that organizations fully develop clinical and administrative leaders and their teams, so they can drive effective clinical and business outcomes alike.
+Physician leaders need to develop their leadership skills, not just their clinical skills
+Nurse managers need tools for feedback & coaching others, to more effectively lead critical/future growth vs. manage current challenges
+Administrative leaders need skills to build collaborative partnerships with clinical leaders & each other
+Organizations need to fill the leadership pipeline and need accessible, effective processes for creating succession & development plans for the next generation of talent
WHO SHOULD ATTEND?
+Healthcare Executives looking to take leading edge leadership talent to the next level
+Healthcare HR & OD leaders responsible for developing both clinical & administrative leaders and improving organizational effectiveness
+Clinical and administrative leaders in the healthcare industry who are looking to develop their own leadership & relationship management skills, build cross-functional relationships & improve team effectiveness
YOU WILL LEARN
+Effective approaches for developing clinical leaders
+High-impact development solutions for administrators
Drug target validation is a major obstacle to drug development leading to high rates of late-stage failure because the pivotal study in drug development - the randomised trial – occurs at the end of the development pipeline.
Genetic studies using the principle of Mendelian randomisation reproduce key elements of a randomised trial ensuring target validation can take place earlier in development.
A second major obstacle in drug development is the understanding of individual differences in drug efficacy and safety due to naturally occurring variation in gene encoding proteins involved in drug disposition – a key component of stratified medicines research.
The Illumina Drug Development Array is designed to address issues and enable genomic discoveries to be used in drug development.
The array combines the genome-wide tag SNP content of the Illumina Human Core BeadChip (240,000 highly-informative genome-wide tag SNPs and over 20,000 high-value markers) with a novel 200,000 custom marker set designed to support studies of drug target validation and treatment response. The array is relevant to full range of human drug targets and medical disorders.
The webinar will:
- Introduce the concept of Mendelian randomisation studies for target selection and validation in drug development
- Discuss the concept of the ‘druggability’ and the ‘druggable genome’
- Describe development of the content of the Illumina drug development array based on an updated set of genes encoding druggable targets and the proteins involved in in drug absorption, distribution, metabolism and excretion (ADME)
- Prof. Aroon Hingorani, Chair of Genetic Epidemiology, Institute of Cardiovascular Science, University College London
- Prof. John Overington, Visiting Professor of Computational Chemical Biology, Institute of Cardiovascular Science, University College London
- Dr. Anna Gaulton, Senior Data Integration and Development Officer – ChEMBL, European Bioinformatics Institute, Hinxton
The HP Helion Development Platform, which sits on top of the HP Helion OpenStack® infrastructure and is built on the CloudFoundry™ open source technology, is a service that enables developers to rapidly develop, deploy and scale applications across a mix of public and private clouds. Join us in learning more about the features and benefits of the HP Helion Development Platform – and learn about what’s new for developers & IT administrators in the newly launched version 1.1.Read more >
Increasingly, enterprises are opening their data and applications to partners, developers, mobile apps and cloud services. In fact, 79% of global organizations enable access to APIs for customers, partners or suppliers.* However, organizations need a better way to address the full breadth of enterprise API management challenges. A way to accelerate application and service release cycles by providing application developers with better API discovery and development tools, constraint free development environments, and faster creation of virtual services with greater fidelity between production and development.Read more >
Tom Hoops, Legg Mason Business DevelopmentRead more >
The influence that supervisors have within an organization’s safety culture cannot be overstated. If safety excellence is the goal, empowering supervisors to leverage positive recognition on the front line is non-negotiable. Join Caterpillar Safety Services Senior Safety Consultant Jenny Krasny as she presents the final installment of a four-part webinar series on supervisor development. Learn why recognizing successful performance is the critical final step in a successful accountability strategy, and how to properly execute it.
• Review of accountability model
• Understand the value of ‘catching’ people doing things right
• Explore the 3W’s (when, what and who) of effective recognition
• Learn the simple steps to create an effective recognition system
Donnie Berkholz leads the development, DevOps and IT ops team at 451 Research. In this talk, he will draw on his experience and research to discuss emerging trends in how software across the stack is created and deployed, with a particular focus on relevance to storage development and usage. Donnie will discuss the potential impacts of these trends to how storage software is built as well as what kinds of new use cases it needs to support.Read more >
Tina Merry from Electronic Arts (EA SPORTS TM) will share the key best practices recommended to achieve effective results when using a distributed development model. The audience will hear about the successes, challenges and lessons learned by the FIFA Street (Vancouver) team in their collaboration with an external partner team based in Russia to create FIFA Street (2012), a product which significantly exceeded sales and quality expectations. The presenter will also draw upon experiences working with game development teams in Spain, Argentina and Romania in collaboration with EA Canada’s FIFA Soccer franchise teams.Read more >
Please join us to discuss the steps and available tools available for development and test on the Microsoft platform on AWS.
In this webinar we will be covering development tools such as Visual Studio and TFS, as well and infrastructure tools such as PowerShell and System Center to help improve productivity for Microsoft developers and testers. We shall also be reviewing the different SDKs and Toolkits that AWS provides to integrate with the Microsoft toolset and improve productivity.
Would you like to cut complexity across all phases of app development and deployment?
Join us for this straightforward discussion on how CA Application Lifecycle Conductor reduces risk through a single source-of-truth. CA Application Lifecycle Conductor automates and manages the software development lifecycles that span mobile-to-mainframe environments — from the initial service desk ticket to the deployment of the application in production.
Join Rose Sakach, Sr. Principal Product Manager, and Vaughn Marshall, Director, Product Management as they outline CA Application Lifecycle Conductor’s many benefits. Discover how you can:
• Create one view and traceability for the application development lifecycle
• Identify the potential time savings for project managers, release managers and compliance managers
• Determine which customer segments would benefit the most from adopting CA ALC
Are you ready to simplify application lifecycle management—from mobile to mainframe?
Are you using open source software components to achieve continuous development and faster cycle times? Does your need for speed conflict with your organization’s open source policies and processes? Hear from Nigel Simpson, Director of Architecture at a major media industry powerhouse on how they built a ‘developer centric’ open source governance strategy that balanced the goals of both development and security.Read more >
G-protein coupled receptors (GPCRs) are the primary target class of currently marketed drugs, accounting for around a third of all drug targets of approved medicines. However, almost all the screening efforts for novel ligand discovery rely exclusively on cellular systems overexpressing the receptors. Current receptor assay systems are based on measurement of either ligand displacement or downstream functional responses, rather than direct observation of ligand binding. Issues of allosteric modulation, probe dependence and functional selectivity create challenges in selecting suitable assays formats. Therefore a method that directly measures GPCR-ligand interactions, independent of binding site, probe and signalling pathway would be a useful primary and orthogonal screening method. An alternative ligand discovery strategy would be the direct measurement of GPCR-ligand interactions by label-free technologies, such as surface plasmon resonance (SPR). However label-free biophysical screening methods have not been routinely applied to membrane proteins. Current developments are looking at improving GPCR biosensor assays for SPR instruments and applying these to a range of drug discovery and biological functions, including kinetic analysis, allosteric discovery, fragment screening and functional selectivity. Biosensor-based direct screening methods enable the identification of the interaction of both orthosteric and allosteric ligands with solubilised, wild type GPCRs, in a label-free and cell-free environment, thus overcoming the limitations of indirect and displacement assay methods.Read more >
What you don't know about your talent could be hurting your organization; learn more about ways to assess your talent and focus career development efforts.Read more >
Your leaders need the skills to provide coaching and guidance to empower their employees to navigate career development options within the organization. Learn tips and tricks on how to make your leader development more effective!Read more >
Watch a replay of the SAP and Google Glass Technical Training on developing Glass Apps with SAP Mobility Software Development Kit
•Overview of SAP mobility software development kit
•Example glass apps built with SAP mobility software development kit
What are the behavioural traits of Generation Z? How do you attract and hold on to them? What media and technology trends do you need to be aware of? More importantly, is your organisation ready for Generation Z?Read more >
A review of aluminium premium development since 2012 – why
there has been such a significant increase in the premium, what are the
key factors that are driving premium, and where the premium will go in
Over the last five years, there has been an explosion of innovation in both web and native technologies. With the rapid release of libraries, frameworks and tools, developers have many options to create applications for this new world. But have design patterns and the general utility of micro-framework stacks really added productive value to full-scale enterprise web development?
Please login to the webinar a few minutes early. We will start the broadcast at 9:45am PDT, and the presentation will begin promptly at 10:00am.
One of the most influential figures in the workplace is the front-line supervisor, who plays a pivotal role in determining what gets done, how it gets done and what gets ignored. Measuring supervisor safety performance, therefore, is critical to ensure the processes designed to build and sustain safety excellence are being completed in a quality way.
Drawing on practical research findings, Caterpillar Safety Services Senior Consultant for Australia, Jenny Krasny, will explain the process of identifying measures that motivate supervisors to lead zero-incident performance on the front line.
•Explore the measures that matter in a culture of safety excellence
•Understand the supervisor’s role in creating and sustaining safety excellence
•Identify the sources of feedback that drive excellent supervisor performance
When faced with increased market pressures and the unavoidable need for change, the first port of call for many organisations is to focus on the skills and capabilities of their people. Indeed, corporate training and development is a growing area. Research shows year on year double-digit growth since 2011 in corporate training spend. And whilst capability and skill development is an inevitable part of organisational development and effectiveness, the question however has to be, are we truly getting the returns on the investments being made? Is capability development meeting the needs of the organisation?
In this webinar Simon Jackson will share his experience and insight that has been developed over many years working with leading global brands on transformation initiatives that have focused on leadership development and change programmes. We will explore what is really needed to transform the capability of your people and create high performance.